tirzepatide sleep issues can cause problems insomnia: what causes and how to fix them Mounjaro, or Tirzepatide, might affect – GLP-1s and Sleep?: How and

Pataer A, Chengcheng G, Ruping S, Correa AM, Fang B, Roth JA, Wistuba II, Swisher SG

However, many people benefit from staying on a lower maintenance dose indefinitely

Any significant alteration in mental wellbeing warrants clinical assessment to identify underlying causes and provide appropriate support

All treatments, including medications, are provided following a thorough medical evaluation and may not be appropriate for certain individuals

[1] A potential tapering approach, based solely on clinical judgment rather than formal guidelines or comparative studies, might involve reducing the dose by one step every 46 weeks

Int J Mol Sci 16(8):1911119129